What Kiniksa Pharmaceuticals International, PLC's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 2 | 39 |
| Total trades | 35 | 146 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 146 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Megna Michael R | CHIEF ACCOUNTING OFFICER | Sep 03 | Open-market sale · S | −4,600 | $80.30 | −$369K | 29,062 |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | Sep 01 | Withheld — tax / exercise cost · F | −4,404 | $79.28 | −$349K | 20,854 |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | Sep 01 | Exercise / conversion · M | +3,069 | — | — | 25,258 |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | Sep 01 | Exercise / conversion · M | +1,591 | — | — | 22,189 |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | Sep 01 | Exercise / conversion · M | +1,750 | — | — | 20,598 |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | Sep 01 | Exercise / conversion · M | +2,694 | — | — | 18,848 |
| Moat Ross | CHIEF OPERATING OFFICER | Sep 01 | Withheld — tax / exercise cost · F | −4,007 | $79.28 | −$318K | 16,307 |
| Moat Ross | CHIEF OPERATING OFFICER | Sep 01 | Exercise / conversion · M | +2,457 | — | — | 20,314 |
| Moat Ross | CHIEF OPERATING OFFICER | Sep 01 | Exercise / conversion · M | +1,740 | — | — | 17,857 |
| Moat Ross | CHIEF OPERATING OFFICER | Sep 01 | Exercise / conversion · M | +1,611 | — | — | 16,117 |
| Moat Ross | CHIEF OPERATING OFFICER | Sep 01 | Exercise / conversion · M | +2,477 | — | — | 14,506 |
| Paolini John | CHIEF MEDICAL OFFICER | Sep 01 | Withheld — tax / exercise cost · F | −4,029 | $79.28 | −$319K | 69,922 |
| Paolini John | CHIEF MEDICAL OFFICER | Sep 01 | Exercise / conversion · M | +2,457 | — | — | 73,951 |
| Paolini John | CHIEF MEDICAL OFFICER | Sep 01 | Exercise / conversion · M | +1,750 | — | — | 71,494 |
| Paolini John | CHIEF MEDICAL OFFICER | Sep 01 | Exercise / conversion · M | +1,624 | — | — | 69,744 |
| Paolini John | CHIEF MEDICAL OFFICER | Sep 01 | Exercise / conversion · M | +2,497 | — | — | 68,120 |
| Patel Sanj K | CHAIRMAN & CEO | Sep 01 | Withheld — tax / exercise cost · F | −15,144 | $79.28 | −$1.2M | 92,348 |
| Patel Sanj K | CHAIRMAN & CEO | Sep 01 | Exercise / conversion · M | +8,609 | — | — | 107,492 |
| Patel Sanj K | CHAIRMAN & CEO | Sep 01 | Exercise / conversion · M | +6,237 | — | — | 98,883 |
| Patel Sanj K | CHAIRMAN & CEO | Sep 01 | Exercise / conversion · M | +6,481 | — | — | 92,646 |
Loading...
